Escholarshipmetadata only
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma
32 biomedical and clinical sciences (for-2020), 3202 clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), health disparities and racial or ethnic minority health research (rcdc), clinical trials and supportive activities (rcdc), cancer (rcdc), patient safety (rcdc), minority health (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 642068
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.